Parsaclisib Active Not Recruiting Phase 2 Trials for Myeloproliferative Neoplasms (MPNs) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02718300A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis